Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts
Abstract Advanced bladder cancer patients show very variable responses to immune checkpoint inhibitors (ICIs) and effective strategies to predict response are still lacking. Here we integrate mutation and gene expression data from 707 advanced bladder cancer patients treated with anti-PD-1/anti-PD-L...
Saved in:
| Main Authors: | Lilian Marie Boll, Sergio Vázquez Montes de Oca, Marta E. Camarena, Robert Castelo, Joaquim Bellmunt, Júlia Perera-Bel, M. Mar Albà |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-02-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-56462-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of exosomes in bladder cancer immunotherapy
by: Mohammad Mousaei Ghasroldasht, et al.
Published: (2025-06-01) -
Exploring the Immunoresponse in Bladder Cancer Immunotherapy
by: Inmaculada Ruiz-Lorente, et al.
Published: (2024-11-01) -
Bladder Cancer Immunotherapy: BCG and Beyond
by: Eric J. Askeland, et al.
Published: (2012-01-01) -
Neoadjuvant immunotherapy driven bladder preservation for muscle invasive bladder cancer
by: Jiao Hu, et al.
Published: (2025-08-01) -
Advances in the immunological microenvironment and immunotherapy of bladder cancer
by: Le Meng, et al.
Published: (2025-08-01)